CMS: Some Drug Makers Incorrectly Report Best Price As More Than Average Manufacturer Price

CMS says some drug manufacturers are incorrectly reporting their quarterly “best price” as higher than the Average Manufacturer Price for the product, and in recently released guidance asks companies to verify the accuracy of their best price before submitting that information to the Drug Data Reporting for Medicaid system. The Medicaid best-price policy requires drug companies to sell drugs at the lowest price available during each rebate period, so if even a single drug is steeply discounted, then all units...